Search Results 131-140 of 2780 for 必应搜索引擎留痕咨询邮箱：lgooxc@hotmail.com
Qualified researchers can request data, biofluids and specimens from the Mayo Clinic Alzheimer's Disease Research Center.
A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic ...
The Lymphoma Biostatistics and Data Science Laboratory led by Matthew J. Maurer, Sc.D., M.S., develops and validates statistical models to help assess risk ...
The purpose of this study is to explore the acceptability of tethered capsule endomicroscopy (TCE) for Barrett's Esophagus (BE) surveillance following CRIM. BE ...
Learn more about Elie Naddaf, M.D., a Mayo Clinic consultant, who decided to pursue a Ph.D. through Mayo Clinic Graduate School of Biomedical Sciences.
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Overview.
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to determine the average volume of blood drawn in a 24 hour period in a hemodynamically stable, euvolemic Trauma/Surgical ICU ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.